23/12/2003

ReGen Therapeutics Plc Placing raises £93,400

17/12/2003

Declaration of Shareholding

12/12/2003

Substantial Shareholding

10/12/2003

Research & Development Update

10/12/2003

Placing raises £655,000

13/11/2003

Notice of EGM

12/11/2003

Results of EGM

08/10/2003

Colostrinin™ Clinical Study to be published in Journal of Alzheimer’s Disease

08/10/2003

Substantial shareholding

24/09/2003

Interim Results for the Six Months to 30 June 2003

23/07/2003

Holding(s) in Company 2003

16/07/2003

Substantial Shareholding 2003

15/07/2003

ReGen Therapeutics placing raises £954,000

03/07/2003

Notification of shareholding 2 – 2003

01/07/2003

Notification of shareholding 1 – 2003

19/06/2003

Disposal of shares 2003

10/06/2003

Results of Annual General Meeting

31/05/2003

The Wall Street Transcript – Interview with Percy Lomax (Executive Chairman)

27/05/2003

Substantial Holdings 2 – 2003

17/04/2003

Interim Funding 2 – 2003

15/04/2003

Substantial Holdings 2003

10/04/2003

Interim Funding 2003

10/03/2003

Capital Reorganisation

05/03/2003

Preliminary results to December 2002

03/03/2003

Results of Extraordinary General Meeting

04/02/2003

Change of adviser 2003

22/01/2003

ReGen Therapeutics enters into Condiditonal Placing Commitment with Jubilee Investment Trust Plc

09/01/2003

ReGen Therapeutics announces grant of U.S patent on use of Colostrinin™ as an oxidative stress regulator